_id
69148eb1ccc777a4e85d9b66
Ticker
PMI
Name
Picard Medical, Inc.
Exchange
NYSE MKT
Address
1992 E Silverlake Road, Tucson, AZ, United States, 85713
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.syncardia.com
Description
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona. Picard Medical, Inc. is a subsidiary of Hunniwell Picard I, Llc.
Last Close
1.82
Volume
315096
Current Price
1.663
Change
-0.15
Last Updated
2026-01-06T09:20:31.918Z
Image
-
Ipo Date
2025-08-29T00:00:00.000Z
Market Cap
174671800
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.99
Sentiment Sources
5
Current Quarter
2025-09-30
Revenue
1187000
Cost Of Revenue
1317000
Gross Profit
-130000
Operating Expenses
3357000
Operating Income
-3487000
Interest Expense
2404000
Pretax Income
-10426000
Net Income
-10426000
Eps
-0.1914708953587499
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-7895000
Operating Margin
-293.7657961246841
Total Other Income Expense Net
-6939000
Cash
2813000
Short Term Investments
-
Receivables
892000
Inventories
6552000
Total Current Assets
11588000
Property Plant Equipment
787000
Total Assets
13521000
Payables
3120000
Short Term Debt
436000
Long Term Debt
44000
Total Liabilities
5553000
Equity
7968000
Bs_currency_symbol
USD
Depreciation
127000
Change In Working Capital
-3286000
Cash From Operations
-6514000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
8949000
Net Change In Cash
2403000
Cf_currency_symbol
USD
PE
-
PB
11.364697392068274
ROE
-130.84839357429718
ROA
-77.10968123659492
FCF
-6514000
Fcf Percent
-5.487784330244313
Piotroski FScore
1
Health Score
23
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1187000
Quarters > 0 > income Statement > cost Of Revenue
1317000
Quarters > 0 > income Statement > gross Profit
-130000
Quarters > 0 > income Statement > operating Expenses
3357000
Quarters > 0 > income Statement > operating Income
-3487000
Quarters > 0 > income Statement > interest Expense
2404000
Quarters > 0 > income Statement > pretax Income
-10426000
Quarters > 0 > income Statement > net Income
-10426000
Quarters > 0 > income Statement > eps
-0.1914708953587499
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
54452140
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7895000
Quarters > 0 > income Statement > operating Margin
-293.7657961246841
Quarters > 0 > income Statement > total Other Income Expense Net
-6939000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2813000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
892000
Quarters > 0 > balance Sheet > inventories
6552000
Quarters > 0 > balance Sheet > total Current Assets
11588000
Quarters > 0 > balance Sheet > property Plant Equipment
787000
Quarters > 0 > balance Sheet > total Assets
13521000
Quarters > 0 > balance Sheet > payables
3120000
Quarters > 0 > balance Sheet > short Term Debt
436000
Quarters > 0 > balance Sheet > long Term Debt
44000
Quarters > 0 > balance Sheet > total Liabilities
5553000
Quarters > 0 > balance Sheet > equity
7968000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-10426000
Quarters > 0 > cash Flow > depreciation
127000
Quarters > 0 > cash Flow > change In Working Capital
-3286000
Quarters > 0 > cash Flow > cash From Operations
-6514000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
8949000
Quarters > 0 > cash Flow > net Change In Cash
2403000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.1914708953587499
Quarters > 0 > ratios > PB
11.364697392068274
Quarters > 0 > ratios > ROE
-130.84839357429718
Quarters > 0 > ratios > ROA
-77.10968123659492
Quarters > 0 > ratios > FCF
-6514000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-5.487784330244313
Quarters > 0 > health Score
23
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
2131000
Quarters > 1 > income Statement > cost Of Revenue
2258000
Quarters > 1 > income Statement > gross Profit
-127000
Quarters > 1 > income Statement > operating Expenses
3394000
Quarters > 1 > income Statement > operating Income
-3521000
Quarters > 1 > income Statement > interest Expense
2427000
Quarters > 1 > income Statement > pretax Income
-6724000
Quarters > 1 > income Statement > net Income
-7520000
Quarters > 1 > income Statement > eps
-0.08523423433021873
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
88227460
Quarters > 1 > income Statement > income Tax Expense
796000
Quarters > 1 > income Statement > EBITDA
-4171000
Quarters > 1 > income Statement > operating Margin
-165.22759267949317
Quarters > 1 > income Statement > total Other Income Expense Net
-3203000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
410000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1300000
Quarters > 1 > balance Sheet > inventories
6996000
Quarters > 1 > balance Sheet > total Current Assets
9643000
Quarters > 1 > balance Sheet > property Plant Equipment
892000
Quarters > 1 > balance Sheet > total Assets
11703000
Quarters > 1 > balance Sheet > payables
6370000
Quarters > 1 > balance Sheet > short Term Debt
15181000
Quarters > 1 > balance Sheet > long Term Debt
61000
Quarters > 1 > balance Sheet > total Liabilities
45931000
Quarters > 1 > balance Sheet > equity
-34228000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6724000
Quarters > 1 > cash Flow > depreciation
126000
Quarters > 1 > cash Flow > change In Working Capital
848000
Quarters > 1 > cash Flow > cash From Operations
-2541000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
0
Quarters > 1 > cash Flow > cash From Financing
2278000
Quarters > 1 > cash Flow > net Change In Cash
-278000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.08523423433021873
Quarters > 1 > ratios > PB
-4.286615226714971
Quarters > 1 > ratios > ROE
21.97031669977796
Quarters > 1 > ratios > ROA
-64.2570281124498
Quarters > 1 > ratios > FCF
-2541000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.1923979352416705
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
620000
Quarters > 2 > income Statement > cost Of Revenue
978000
Quarters > 2 > income Statement > gross Profit
-358000
Quarters > 2 > income Statement > operating Expenses
2888000
Quarters > 2 > income Statement > operating Income
-3246000
Quarters > 2 > income Statement > interest Expense
555000
Quarters > 2 > income Statement > pretax Income
-5530000
Quarters > 2 > income Statement > net Income
-5561000
Quarters > 2 > income Statement > eps
-0.07717593103511063
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
72056144
Quarters > 2 > income Statement > income Tax Expense
31000
Quarters > 2 > income Statement > EBITDA
-4846000
Quarters > 2 > income Statement > operating Margin
-523.5483870967741
Quarters > 2 > income Statement > total Other Income Expense Net
-2284000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
688000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
119000
Quarters > 2 > balance Sheet > inventories
8043000
Quarters > 2 > balance Sheet > total Current Assets
9777000
Quarters > 2 > balance Sheet > property Plant Equipment
997000
Quarters > 2 > balance Sheet > total Assets
11963000
Quarters > 2 > balance Sheet > payables
5520000
Quarters > 2 > balance Sheet > short Term Debt
22405000
Quarters > 2 > balance Sheet > long Term Debt
79000
Quarters > 2 > balance Sheet > total Liabilities
40620000
Quarters > 2 > balance Sheet > equity
-28657000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-5561000
Quarters > 2 > cash Flow > depreciation
129000
Quarters > 2 > cash Flow > change In Working Capital
736000
Quarters > 2 > cash Flow > cash From Operations
-2241000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
0
Quarters > 2 > cash Flow > cash From Financing
2834000
Quarters > 2 > cash Flow > net Change In Cash
592000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.07717593103511063
Quarters > 2 > ratios > PB
-4.181504256272464
Quarters > 2 > ratios > ROE
19.405380884251667
Quarters > 2 > ratios > ROA
-46.484995402491016
Quarters > 2 > ratios > FCF
-2241000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-3.6145161290322583
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
836000
Quarters > 3 > income Statement > cost Of Revenue
700000
Quarters > 3 > income Statement > gross Profit
136000
Quarters > 3 > income Statement > operating Expenses
3708000
Quarters > 3 > income Statement > operating Income
-3572000
Quarters > 3 > income Statement > interest Expense
1431000
Quarters > 3 > income Statement > pretax Income
-8853000
Quarters > 3 > income Statement > net Income
-8838000
Quarters > 3 > income Statement > eps
-0.12265435685817437
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
72056144
Quarters > 3 > income Statement > income Tax Expense
-15000
Quarters > 3 > income Statement > EBITDA
-7296000
Quarters > 3 > income Statement > operating Margin
-427.27272727272725
Quarters > 3 > income Statement > total Other Income Expense Net
-5281000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
96000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
625000
Quarters > 3 > balance Sheet > inventories
8115000
Quarters > 3 > balance Sheet > total Current Assets
9791000
Quarters > 3 > balance Sheet > property Plant Equipment
1104000
Quarters > 3 > balance Sheet > total Assets
12106000
Quarters > 3 > balance Sheet > payables
5293000
Quarters > 3 > balance Sheet > short Term Debt
20410000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
35842000
Quarters > 3 > balance Sheet > equity
-23736000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-8838000
Quarters > 3 > cash Flow > depreciation
126000
Quarters > 3 > cash Flow > change In Working Capital
767000
Quarters > 3 > cash Flow > cash From Operations
-3152000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
3233000
Quarters > 3 > cash Flow > net Change In Cash
90000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.12265435685817437
Quarters > 3 > ratios > PB
-5.048422963936637
Quarters > 3 > ratios > ROE
37.23458038422649
Quarters > 3 > ratios > ROA
-73.00512142739137
Quarters > 3 > ratios > FCF
-3152000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-3.770334928229665
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
4391000
Annuals > 0 > income Statement > cost Of Revenue
4503000
Annuals > 0 > income Statement > gross Profit
-112000
Annuals > 0 > income Statement > operating Expenses
13600000
Annuals > 0 > income Statement > operating Income
-13712000
Annuals > 0 > income Statement > interest Expense
3067000
Annuals > 0 > income Statement > pretax Income
-21070000
Annuals > 0 > income Statement > net Income
-21055000
Annuals > 0 > income Statement > eps
-0.29220270238163176
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
72056144
Annuals > 0 > income Statement > income Tax Expense
-15000
Annuals > 0 > income Statement > EBITDA
-17460000
Annuals > 0 > income Statement > operating Margin
-312.2751081758142
Annuals > 0 > income Statement > total Other Income Expense Net
-7358000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
96000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
625000
Annuals > 0 > balance Sheet > inventories
8115000
Annuals > 0 > balance Sheet > total Current Assets
9791000
Annuals > 0 > balance Sheet > property Plant Equipment
1104000
Annuals > 0 > balance Sheet > total Assets
12106000
Annuals > 0 > balance Sheet > payables
5293000
Annuals > 0 > balance Sheet > short Term Debt
20410000
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
35842000
Annuals > 0 > balance Sheet > equity
-23736000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-21055000
Annuals > 0 > cash Flow > depreciation
543000
Annuals > 0 > cash Flow > change In Working Capital
963000
Annuals > 0 > cash Flow > cash From Operations
-11874000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
0
Annuals > 0 > cash Flow > cash From Financing
11741000
Annuals > 0 > cash Flow > net Change In Cash
-148000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.29220270238163176
Annuals > 0 > ratios > PB
-5.06967309066397
Annuals > 0 > ratios > ROE
88.70492079541624
Annuals > 0 > ratios > ROA
-173.9220221377829
Annuals > 0 > ratios > FCF
-11874000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2.704167615577317
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
5043000
Annuals > 1 > income Statement > cost Of Revenue
7354000
Annuals > 1 > income Statement > gross Profit
-2311000
Annuals > 1 > income Statement > operating Expenses
13191000
Annuals > 1 > income Statement > operating Income
-15502000
Annuals > 1 > income Statement > interest Expense
140000
Annuals > 1 > income Statement > pretax Income
-15571000
Annuals > 1 > income Statement > net Income
-15569000
Annuals > 1 > income Statement > eps
-0.2160676263775647
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
72056144
Annuals > 1 > income Statement > income Tax Expense
-2000
Annuals > 1 > income Statement > EBITDA
-14846000
Annuals > 1 > income Statement > operating Margin
-307.3963910370811
Annuals > 1 > income Statement > total Other Income Expense Net
-69000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
244000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
741000
Annuals > 1 > balance Sheet > inventories
6893000
Annuals > 1 > balance Sheet > total Current Assets
8761000
Annuals > 1 > balance Sheet > property Plant Equipment
1314000
Annuals > 1 > balance Sheet > total Assets
11374000
Annuals > 1 > balance Sheet > payables
3083000
Annuals > 1 > balance Sheet > short Term Debt
4367000
Annuals > 1 > balance Sheet > long Term Debt
4282000
Annuals > 1 > balance Sheet > total Liabilities
14926000
Annuals > 1 > balance Sheet > equity
-3552000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-15569000
Annuals > 1 > cash Flow > depreciation
585000
Annuals > 1 > cash Flow > change In Working Capital
3280000
Annuals > 1 > cash Flow > cash From Operations
-10634000
Annuals > 1 > cash Flow > capital Expenditures
7000
Annuals > 1 > cash Flow > cash From Investing
-9000
Annuals > 1 > cash Flow > cash From Financing
10840000
Annuals > 1 > cash Flow > net Change In Cash
92000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.2160676263775647
Annuals > 1 > ratios > PB
-33.87774788288288
Annuals > 1 > ratios > ROE
438.31644144144144
Annuals > 1 > ratios > ROA
-136.88236328468437
Annuals > 1 > ratios > FCF
-10641000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.110053539559786
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
4113000
Annuals > 2 > income Statement > cost Of Revenue
9101000
Annuals > 2 > income Statement > gross Profit
-4988000
Annuals > 2 > income Statement > operating Expenses
6079000
Annuals > 2 > income Statement > operating Income
-11067000
Annuals > 2 > income Statement > interest Expense
5000
Annuals > 2 > income Statement > pretax Income
-11157000
Annuals > 2 > income Statement > net Income
-11168000
Annuals > 2 > income Statement > eps
-0.15499025315592796
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
72056144
Annuals > 2 > income Statement > income Tax Expense
11000
Annuals > 2 > income Statement > EBITDA
-10607000
Annuals > 2 > income Statement > operating Margin
-269.07366885485044
Annuals > 2 > income Statement > total Other Income Expense Net
-90000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
152000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
3642000
Annuals > 2 > balance Sheet > inventories
7326000
Annuals > 2 > balance Sheet > total Current Assets
12123000
Annuals > 2 > balance Sheet > property Plant Equipment
1931000
Annuals > 2 > balance Sheet > total Assets
15440000
Annuals > 2 > balance Sheet > payables
1392000
Annuals > 2 > balance Sheet > short Term Debt
887000
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
4071000
Annuals > 2 > balance Sheet > equity
11369000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-11168000
Annuals > 2 > cash Flow > depreciation
545000
Annuals > 2 > cash Flow > change In Working Capital
-1926000
Annuals > 2 > cash Flow > cash From Operations
-10723000
Annuals > 2 > cash Flow > capital Expenditures
29000
Annuals > 2 > cash Flow > cash From Investing
-37000
Annuals > 2 > cash Flow > cash From Financing
5524000
Annuals > 2 > cash Flow > net Change In Cash
-5102000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.15499025315592796
Annuals > 2 > ratios > PB
10.584375097194124
Annuals > 2 > ratios > ROE
-98.23203447972557
Annuals > 2 > ratios > ROA
-72.33160621761658
Annuals > 2 > ratios > FCF
-10752000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.614150255288111
Annuals > 2 > health Score
26
Valuation > metrics > PE
-0.1914708953587499
Valuation > metrics > PB
11.364697392068274
Valuation > final Score
20
Valuation > verdict
278.8% Overvalued
Profitability > metrics > ROE
-130.84839357429718
Profitability > metrics > ROA
-89.97238522609597
Profitability > metrics > Net Margin
-8.783487784330244
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6969126506024096
Risk > metrics > Interest Coverage
-1.4504991680532446
Risk > final Score
42
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.2587176602924632
Liquidity > metrics > Quick Ratio
1.4161979752530933
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
39
Prev Profitabilities > 2
40
Prev Risks > 0
24
Prev Risks > 1
7
Prev Risks > 2
20
Prev Liquidities > 0
16
Prev Liquidities > 1
13
Prev Liquidities > 2
13
Updated At
2026-01-20T22:24:32.416Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-31
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-14
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.1915
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-07-14
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.8
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.8
Earnings History > 2 > surprise Percent
-
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona. Picard Medical, Inc. is a subsidiary of Hunniwell Picard I, Llc.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APMI.SW Philip Morris (SIX) +12.61% pre-market 19 Jan 2026: CHF134.00 momentum Meyka
Read more →Philip Morris stock heads into MLK Day break higher — here’s what matters next - TechStock²
1/18/2026
Philip Morris stock heads into MLK Day break higher — here’s what matters next TechStock²
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Picard Medical, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.1915
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.